Abstrakt
The invention relates to methods of treating cognitive dysfunction and improving cognitive functioning comprising the administration of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a pharmaceutically acceptable salt thereof to a patient in need thereof. Moreover the invention relates to an improved binder in a composition comprising 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine.
Originalsprog | Engelsk |
---|---|
IPC | A61P 25/ 18 A I |
Patentnummer | US2011207744 |
Land/Område | Danmark |
Prioritetsdato | 05/05/2011 |
Prioritetsnummer | US201113101176 |
Status | Udgivet - 25. aug. 2011 |
Udgivet eksternt | Ja |